相关实验视频
Updated: Jun 29, 2025
09:49
Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
1.3K
一个mRNA面板用于区分COPD患者的急性恶化或肺炎
Wilhelm Bertrams1,2, Jochen Wilhelm3,4, Pia-Marie Veeger1,2
1Institute for Lung Research, Philipps University Marburg, Marburg, Germany.
Frontiers in medicine
|April 8, 2024
概括
周围血液单核细胞中的新基因标记物YWHAG,E2F1和TDRD9准确地区分慢性阻塞性肺病 (AECOPD) 和社区获得性肺炎 (CAP) 的急性恶化. 这有助于及时和适当的患者治疗.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 分子生物学分子生物学
- 生物标志物发现发现
背景情况:
- 慢性阻塞性肺病 (COPD) 患者容易发生急性恶化 (AECOPD) 和社区获得性肺炎 (CAP),两者都会导致严重的健康风险.
- 由于病因,治疗和预后的差异,区分AECOPD和CAP至关重要,但目前还没有可靠的生物标志物.
研究的目的:
- 评估特定的外周血液单核细胞 (PBMC) 转录的潜力,以区分AECOPD,COPD与CAP和CAP没有先前的COPD.
主要方法:
- 从患有AECOPD,COPD+CAP和没有COPD的CAP患者的PBMC中分析候选基因转录.
- 测试选定的转录 (YWHAG,E2F1,TDRD9) 的预测能力,并将它们的准确性与传统的临床标记 (CRP,淋巴细胞,中性粒细胞计数) 进行比较.
主要成果:
- 包含YWHAG,E2F1和TDRD9的基因组表现出高预测能力,达到高达100%的模型准确性.
- 这种转录集显著超过了经典的临床标记,其最大模型准确度为82%.
结论:
- 在PBMC中YWHAG,E2F1和TDRD9的表达水平可以准确地区分经历急性恶化和社区获得肺炎的COPD患者.
- 这些发现表明,对于COPD患者的呼吸道感染,这是一种有希望的新诊断方法.
相关概念视频
01:30Pneumonia III: Complications and Assessment
205
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
205
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:28Pneumonia IV: Management
324
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324
01:29Pneumonia II: Pathophysiology
262
The pathophysiology of pneumonia involves the following steps:
262
01:23Assessment of Respiration
1.1K
The respiratory system's basic structures and primary functions lay the foundation for nurses' comprehensive respiratory assessments. This assessment includes subjective and objective data to gauge the patient's respiratory health.
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like...
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like...
1.1K
01:30Pneumonia I: Introduction
230
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
230